Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Genome-wide Association Studies-GWAS

Genome-wide Association Studies-GWAS

Genome-wide association studies or GWAS are used to identify whether common SNPs are associated with certain diseases. Suppose specific SNPs are more frequently observed in individuals with a particular disease than those without the disease. In that case, those SNPs are said to be associated with the disease. Chi-square analysis is performed to check the probability of the allele likely to be associated with the disease.
GWAS does not require the identification of the target gene involved in...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Polygenic risk and air pollution trends in relation to type 2 diabetes: evidence from the Taiwan Biobank.

Diabetology & metabolic syndrome·2026

Same author

Association between hot spring residency and dry eye disease: a crossover gene-environment interaction (GxE) study in Taiwan.

Human genomics·2025

Same author

Population-specific polygenic risk scores for people of Han Chinese ancestry.

Nature·2025

Same author

Sex-Specific Polygenic Risk Scores and Replication in a Model-Free Analysis of Schizophrenia Data.

Genes·2025

Same author

Voluntary vitamin D testing: a decade-long study of utilisation patterns and impact on deficiency outcomes in Taiwan.

Public health nutrition·2025

Same author

The Myopic Control Effect of Defocus Incorporated Multiple Segments' Spectacle Lens With Atropine in High Myopia Population.

In vivo (Athens, Greece)·2025

Search research articles

Related Experiment Video

Updated: Dec 15, 2025

Navigating MARRVEL, a Web-Based Tool that Integrates Human Genomics and Model Organism Genetics Information

Navigating MARRVEL, a Web-Based Tool that Integrates Human Genomics and Model Organism Genetics Information

Published on: August 15, 2019

Maximal Segmental Score Method for Localizing Recessive Disease Variants Based on Sequence Data.

Ai-Ru Hsieh¹, Jia Jyun Sie², Chien Ching Chang³

¹Department of Statistics, Tamkang University, New Taipei, Taiwan.

Frontiers in Genetics

|July 14, 2020

Summary

This summary is machine-generated.

A new method, expanded maximal segmental score (eMSS), enhances genetic association studies for rare diseases by analyzing whole-genome sequences. eMSS effectively identifies disease-associated segments in small sample sizes, outperforming existing methods.

Keywords:

ALSPAC autosomal recessive disease maximal segmental score rare disease whole-genome sequencing

More Related Videos

Detection of Rare Genomic Variants from Pooled Sequencing Using SPLINTER

Detection of Rare Genomic Variants from Pooled Sequencing Using SPLINTER

Published on: June 23, 2012

Determining the Likelihood of Variant Pathogenicity Using Amino Acid-level Signal-to-Noise Analysis of Genetic Variation

Determining the Likelihood of Variant Pathogenicity Using Amino Acid-level Signal-to-Noise Analysis of Genetic Variation

Published on: January 16, 2019

Related Experiment Videos

Last Updated: Dec 15, 2025

Navigating MARRVEL, a Web-Based Tool that Integrates Human Genomics and Model Organism Genetics Information

Navigating MARRVEL, a Web-Based Tool that Integrates Human Genomics and Model Organism Genetics Information

Published on: August 15, 2019

Detection of Rare Genomic Variants from Pooled Sequencing Using SPLINTER

Detection of Rare Genomic Variants from Pooled Sequencing Using SPLINTER

Published on: June 23, 2012

Determining the Likelihood of Variant Pathogenicity Using Amino Acid-level Signal-to-Noise Analysis of Genetic Variation

Determining the Likelihood of Variant Pathogenicity Using Amino Acid-level Signal-to-Noise Analysis of Genetic Variation

Published on: January 16, 2019

Area of Science:

Genetics
Bioinformatics
Computational Biology

Background:

Whole-genome sequencing is increasingly affordable, enabling genetic association studies for rare diseases.
Traditional methods often rely on homozygosity mapping and fixed parameters, limiting power for rare conditions.

Purpose of the Study:

To introduce and evaluate the expanded maximal segmental score (eMSS), a novel region-specific method for genetic association analysis.
To assess eMSS's performance in detecting disease-associated segments using whole-genome sequence data, particularly for rare autosomal recessive diseases.

Main Methods:

eMSS converts p-values into continuous scores, analyzing whole-genome sequence data beyond homozygosity regions.
It does not require predefined parameters like window size or SNP count, unlike traditional sliding window approaches.
Performance was validated through simulations and real data analysis for multiple intestinal atresia (MIA) and osteogenesis imperfecta (OI), comparing with HDR-del.

Main Results:

Simulations demonstrated eMSS's high power, especially with decreased non-causal haplotype blocks, and well-controlled type I error rates (p < 0.05).
Real data analysis identified candidate genes (BMP1, VDR, TTC7A) associated with OI and MIA.
eMSS effectively reduced candidate variants to a small set of pathogenic variants for these rare diseases.

Conclusions:

eMSS is a powerful tool for analyzing small cohorts of recessive cases, outperforming HDR-del in identifying disease-associated variants.
The method offers a lower computational burden and reduced computation time (3/5 of HDR-del) due to the absence of additional parameter settings.
eMSS effectively narrows down candidate variants for rare diseases like OI and MIA.